Cargando…

Adrenocortical Production Is Associated with Higher Levels of Luteinizing Hormone in Nonobese Women with Polycystic Ovary Syndrome

Objective. Insulin resistance (IR) and ovarian and adrenal hyperandrogenism are a common finding in women with polycystic ovary syndrome (PCOS). The aim of the present study was to access possible differences in insulin resistance, gonadotropins, and androgens production in obese and nonobese PCOS w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tock, Luciana, Carneiro, Gláucia, Pereira, Andrea Z., Tufik, Sérgio, Zanella, Maria Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033536/ https://www.ncbi.nlm.nih.gov/pubmed/24895496 http://dx.doi.org/10.1155/2014/620605

Ejemplares similares

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis
por: Lin, Kainan, et al.
Publicado: (2021)

Role of luteinizing hormone elevation in outcomes of ovulation induction with letrozole for polycystic ovary syndrome
por: Fu, Wenyan, et al.
Publicado: (2023)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome
por: Chun, Sungwook
Publicado: (2014)

Do basal Luteinizing Hormone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio Have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Singh, Neeta, et al.
Publicado: (2021)

Do Basal Luteinizing Hormone and Luteinizing Hormone/ Follicle-Stimulating Hormone Ratio have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Neeta, Singh, et al.
Publicado: (2021)

Do Basal Luteinizing Hormone and Luteinizing Hormone/Follicle- Stimulating Hormone Ratio have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women
por: Tola, Hafza, et al.
Publicado: (2018)

Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome
por: Satyaraddi, Anil, et al.
Publicado: (2019)

Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome
por: Pokorska-Niewiada, Kamila, et al.
Publicado: (2022)

Laparoscopic Ovarian Drilling Reduces Testosterone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio and Improves Clinical Outcome in Women with Polycystic Ovary Syndrome
por: Sinha, Priyanka, et al.
Publicado: (2019)

Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
por: Alhassan, Samia, et al.
Publicado: (2023)

Association of Mean Platelet Volume With Androgens and Insulin Resistance in Nonobese Patients With Polycystic Ovary Syndrome
por: Dogan, Bercem Aycicek, et al.
Publicado: (2014)

Activation of arcuate nucleus GABA neurons promotes luteinizing hormone secretion and reproductive dysfunction: Implications for polycystic ovary syndrome
por: Silva, Mauro S.B., et al.
Publicado: (2019)

An administration of TAK-683 at a minimally effective dose for luteinizing hormone stimulation under the absence of the ovary induces luteinizing hormone surge in ovary-intact goats
por: KANAI, Nahoko, et al.
Publicado: (2017)

Influence of Menopausal Hormone Therapy on Body Composition and Metabolic Parameters
por: Costa, Graciela B.C., et al.
Publicado: (2020)

Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination
por: Wang, Bin, et al.
Publicado: (2023)

Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome
por: Boumosleh, Jocelyne Matar, et al.
Publicado: (2017)

Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome
por: Cinar, Nese, et al.
Publicado: (2012)

Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia
por: Ramezanali, Fariba, et al.
Publicado: (2016)

Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
por: Liu, Wenhua, et al.
Publicado: (2022)

Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
por: Schniewind, Hanna A., et al.
Publicado: (2021)

Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol
por: Chen, Chen, et al.
Publicado: (2022)

miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome
por: Dai, Hongmei, et al.
Publicado: (2022)

Effects of Ketogenic Diet on Reproductive Hormones in Women With Polycystic Ovary Syndrome
por: Khalid, Karniza, et al.
Publicado: (2023)

Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome
por: Ciccone, Marco Matteo, et al.
Publicado: (2009)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

Normal Testosterone but Higher Luteinizing Hormone Plasma Levels in Men With Hypersexual Disorder
por: Chatzittofis, Andreas, et al.
Publicado: (2020)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
por: Jena, Sweekruti, et al.
Publicado: (2023)

Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka
por: Ogiwara, Katsueki, et al.
Publicado: (2013)

Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome
por: Khani, Behnaz, et al.
Publicado: (2011)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
por: de Melo, Anderson Sanches, et al.
Publicado: (2017)

A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
por: Shele, Grei, et al.
Publicado: (2020)

Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome
por: Bizoń, Anna, et al.
Publicado: (2021)

Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
por: di Clemente, Nathalie, et al.
Publicado: (2022)

Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls
por: Forslund, Maria, et al.
Publicado: (2018)

Insulin Resistance, Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome
por: Cree-Green, Melanie, et al.
Publicado: (2017)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5dfv5c2hd169i9ptksra9125t